Veracyte, Inc. (VCYT)

Veracyte Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	375.47	361.05	296.54	219.51	117.48	120.37
Revenue Growth (YoY)	20.66%	21.76%	35.09%	86.85%	-2.40%	30.82%
Cost of Revenue	118.14	112.9	101.58	74.4	41.46	36.52
Gross Profit	257.34	248.15	194.95	145.11	76.03	83.85
Selling, General & Admin	190.53	187.72	170.76	181.19	89.12	82.72
Research & Development	60.5	57.31	40.6	29.84	17.2	14.85
Other Operating Expenses	86.26	88.92	24.67	15.98	5.1	1.4
Operating Expenses	337.29	333.94	236.04	227.02	111.42	98.97
Operating Income	-79.95	-85.8	-41.08	-81.9	-35.39	-15.13
Other Expense / Income	-9.52	-9.18	-4.65	-0.25	-0.48	-2.53
Pretax Income	-70.43	-76.61	-36.43	-81.65	-34.91	-12.6
Income Tax	-2.25	-2.21	0.13	-6.09	0	0
Net Income	-68.18	-74.4	-36.56	-75.56	-34.91	-12.6
Shares Outstanding (Basic)	75	73	72	68	53	46
Shares Outstanding (Diluted)	75	73	72	68	53	46
Shares Change	3.58%	1.53%	5.39%	27.52%	15.39%	24.63%
EPS (Basic)	-0.93	-1.02	-0.51	-1.11	-0.66	-0.27
EPS (Diluted)	-0.93	-1.02	-0.51	-1.11	-0.66	-0.27
Free Cash Flow	26.33	34.26	-1.01	-37	-12.55	-5.97
Free Cash Flow Per Share	0.35	0.47	-0.01	-0.55	-0.24	-0.13
Gross Margin	68.54%	68.73%	65.74%	66.11%	64.71%	69.66%
Operating Margin	-21.29%	-23.76%	-13.85%	-37.31%	-30.12%	-12.57%
Profit Margin	-18.16%	-20.61%	-12.33%	-34.42%	-29.71%	-10.47%
Free Cash Flow Margin	7.01%	9.49%	-0.34%	-16.85%	-10.68%	-4.96%
EBITDA	-39.93	-45.27	-7.18	-60.42	-26	-7.45
EBITDA Margin	-10.63%	-12.54%	-2.42%	-27.53%	-22.13%	-6.19%
Depreciation & Amortization	30.5	31.35	29.25	21.23	8.91	5.15
EBIT	-70.43	-76.61	-36.43	-81.65	-34.91	-12.6
EBIT Margin	-18.76%	-21.22%	-12.28%	-37.20%	-29.71%	-10.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).